Clinical Trial Update: Infliximab Therapy in Patients With Refractory Polymyalgia Rheumatica [Phase 3]

View source ↗

Summary

Phase 3 study of infliximab for refractory polymyalgia rheumatica is being updated; no results are provided in the available snippet.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Polymyalgia Rheumatica

Drugs mentioned

• Infliximab (infliximab)

Snippet

Sponsor: Hospital Universitario Marqués de Valdecilla | Conditions: Polymyalgia Rheumatica | Phase 3 | Status: UNKNOWN